Execs face boardroom pressure to scale AI fast, but talent gaps, infrastructure issues, and employee resistance are holding progress back.

Almost nine in 10 (86%) US contact center decision-makers are either currently using AI for in-call agent assistance or plan to do so in the next two years, according to January data from ContactBabel and CallMiner.

In its new study “Gen Z and the American Dream,” social and advertising agency Adolescent Content was surprised to draw similarities between Gen Z and Boomers—two generations often perceived as being at odds.

Amazon insists it won’t display tariff costs on products after White House backlash: Despite political heat, radical transparency may be best for retailers in an uncertain environment.

Undisclosed bots targeting polarizing issues expose a glaring vulnerability—threatening Reddit’s brand as a forum for real voices just as its ad ambitions expand.

Agent Pay could transform the payments experience for consumers with hyperpersonalized recommendations

Marketers face rising pressure from tariffs, triopoly dominance: Growth is coming from mid-tier platforms and smarter strategies, EMARKETER analysts say at Possible conference.

ChatGPT's shopping tool threatens retail media revenues: Its product search could siphon ad dollars from retailers struggling with tariffs, higher prices, and weak demand.

TikTok makes a bid to encourage creators, agencies to livestream: The push is part of the platform’s strategic effort to avoid a US ban.

Minimalist trucks, maximalist ambitions: EV makers Slate and TELO are betting that simple, compact, and affordable EVs will resonate with buyers who are tired of bloated features and high price tags.

Nobody knows what’s ahead: Macroeconomic turmoil and shifting tariff policies make forecasting a guessing game that many consumer brands are opting out of.

Google aims to reset its ecosystem with AI-infused Pixel updates and expansion beyond phones—countering fragmentation and pressure from rivals.

Vaccine integrity project launched to counter medical misinformation: Vaccine makers have the tough job of currying favor with Trump’s health administration, while preserving the public’s trust in their medicines.

Novo Nordisk and Hims go from competitors to partners: The deal signals Novo’s desire to capture patients transitioning off compounded GLP-1s. All eyes turn to Eli Lilly, which at last check said it’s not affiliating with Hims.

Congress wants to end the pharma industry’s advertising expense write-offs: This has been proposed before, but under the new Trump administration’s anti-drug advertising stance, the bill could gain more traction and inspire other new rules.

Spotify showed resilience with strong Q1 gains: Still, margin pressures and licensing costs could challenge momentum ahead.